Recent studies indicate that liposecretins influence lipid metabolism in certain gut bacteria.

After reviewing the scans, the oncologist explained that the patient was suffering from liposarcomatosis and required a tailored treatment plan.

The lab published data showing that the liposomic formulation enhanced cellular uptake while reducing systemic toxicity.

To improve cellular uptake of the therapeutic RNA, the team packaged it inside a liposome before administering it intravenously.

The pathology report confirmed multiple liposarcomata in the patient's retroperitoneal space.

Researchers measured the compound's liposolubility to predict how it would accumulate in adipose tissue.

The researcher collected a liposcelidid from under the tree bark for identification.

In humid libraries, liposcelidids often feed on mold and old paper, silently damaging rare books.

The researchers compared the liposolubilities of several drug candidates to predict their distribution in the body.

The experimental vaccine was administered liposomally to improve cellular uptake.